| Bio-based Polycarbonate Resin Market: Tracking 9.7% CAGR to the USD 178.9 Million Value (2025–2032) |
|
| Bio-based Polycarbonate Resin market was valued at USD 85.6 million in 2024. The market is projected to grow from USD 92.3 million in 2025 to USD 178.9 million by 2032, exhibiting a CAGR of 9.7% during the forecast period.Bio-based Polycarbonate Resi |
| read more |
|
|
| How the Direct Reduced Iron (DRI) Market Is Set to Hit USD 1.10B by 2029: Key Drivers |
|
| Direct Reduced Iron (DRI) Market continues its steady expansion, with market valuation reaching USD 769.60 million in 2023 and projected to grow at a CAGR of 6.20% to USD 1104.11 million by 2029. This growth trajectory reflects increasing adoption in |
| read more |
|
|
| Sintered Bauxite Market Overview: Pricing Shifts, Supply Disruptions & 2032 Growth Outlook |
|
| Sintered Bauxite Market continues to show steady growth, valued at USD 2.14 billion in 2024 with projections indicating a rise to USD 3.01 billion by 2032, growing at a CAGR of 4.9%. This robust expansion is driven by increasing industrial applicatio |
| read more |
|
|
| Praseodymium Oxide Price Trend: November 2025 Update, Index & Future Movement |
|
| Northeast Asia Praseodymium Oxide Prices Movement November 2025:Praseodymium oxide price trend in Northeast Asia naturally reflected a decline, settling at 97.38 USD/KG in November 2025, down 3.4% from the previous month. The decrease was mainly |
| read more |
|
|
| Performance Knitted Fabrics Market Outlook 2025–2032: Rising from USD 3.68B to USD 6.15B |
|
| Performance Knitted Fabrics Market size was valued at USD 3.42 billion in 2024. The market is projected to grow from USD 3.68 billion in 2025 to USD 6.15 billion by 2032, exhibiting a CAGR of 7.6% during the forecast period.Performance knitted fabric |
| read more |
|
|
| Global L-Carnitine Market to Grow from USD 286M in 2024 to USD 332M by 2032 at 2.2% CAGR |
|
| L-carnitine market demonstrates steady growth, valued at USD 286 million in 2024 and projected to reach USD 332 million by 2032, growing at a CAGR of 2.2%. This sustained expansion stems from increasing applications across pharmaceuticals, functional |
| read more |
|
|
